Prospective Cohort Study of Rapid Response Team

Clinical Trial Description

acutely deteriorating patients including sudden cardiac arrest in general ward who are monitored and intervened by rapid response team ;

Study Design

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04507737` - Rapid Response Teams - How and Who?	N/A
Completed	`NCT01551160` - Impact of a Communication and Team-working Intervention on Performance and Effectiveness of a Medical Emergency Team	N/A
Not yet recruiting	`NCT04951973` - Deep Learning Based Early Warning Score in Rapid Response Team Activation

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT04507737 - Rapid Response Teams - How and Who?

N/A

Completed

NCT01551160 - Impact of a Communication and Team-working Intervention on Performance and Effectiveness of a Medical Emergency Team

N/A

Not yet recruiting

NCT04951973 - Deep Learning Based Early Warning Score in Rapid Response Team Activation

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02986581
Study type	Observational [Patient Registry]
Source	Seoul National University Hospital
Contact	Yeon Joo Lee, MD
Email	yjlee1117@snubh.org
Status	Recruiting
Phase
Start date	November 2016
Completion date	November 2026

Prospective Cohort Study of Rapid Response Team

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms